Compare AdaptHealth Corp (AHCO) vs Crown Castle International Corp (CCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Crown Castle International Corp — how do they compare? AdaptHealth Corp trades at $5.75 (market cap $753.09M), while Crown Castle International Corp trades at $73.76 (market cap $31.33B). The key difference: Crown Castle International Corp is far larger — about 41.6× AdaptHealth Corp's market cap, and Crown Castle International Corp pays a 5.77% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | CCI | |
|---|---|---|
Market Cap | $753.09M | $31.33B |
Sector | Health | Real Estate |
52-Week High | $13.38 | $103.79 |
52-Week Low | $5.22 | $73.61 |
Enterprise Value | $2.77B | $53.69B |
Dividend Yield | — | 5.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth Corp. (AHCO) trades at $5.74, up 9.96% in the last session, yet remains under pressure with a bearish technical signal and recent earnings misses. The company reported a Q2 2026 net loss of $228 million with a -6.82% margin, while selling its diabetes unit to focus on sleep and respiratory care. Valuation ratios show a low P/S of 0.23 and P/B of 0.55, but negative profitability metrics highlight operational challenges.
The outlook is mixed: analyst consensus is bullish with a $11 price target, but risks include ongoing losses, fraud investigations, and cost overruns in fixed-price contracts. Upside depends on successful business restructuring and margin improvement, while downside risks from legal and execution issues persist.
Crown Castle (CCI) trades at $73.98, near 52-week lows, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 AFFO of $1.13 per share, beating estimates, and raised full-year guidance amid its transition to a pure-play U.S. tower operator. Revenue declined to $4.26B in 2025 but profitability improved with 20.72% net margin. Analyst consensus remains divided with 50% buy ratings and $95.29 price target suggesting 29% upside.
The stock presents a value opportunity with discounted valuation and 5.5% dividend yield, but faces headwinds from high debt levels (77.21% debt-to-asset ratio) and competitive pressure in the tower REIT sector. Recent institutional selling and technical weakness indicate near-term caution despite long-term growth potential from wireless infrastructure demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Crown Castle International Corp
Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.
Read more on CCI →
